Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sundrug Co ( (JP:9989) ) has provided an update.
Sundrug Co., Ltd., a leading Japanese drugstore and pharmacy chain listed in Tokyo, focuses on retailing pharmaceuticals, cosmetics and daily necessities to consumers seeking affordable, convenient healthcare and lifestyle products. The company has steadily expanded its footprint and maintains a solid equity base, reflecting a relatively conservative balance sheet in the domestic drugstore retail market.
For the fiscal year ended 31 March 2026, Sundrug reported net sales of ¥842.5 billion, up 5.1% year-on-year, with operating profit rising 5.2% to ¥46.8 billion and profit attributable to owners of the parent edging up 2.1% to ¥31.4 billion. Cash flows from operating activities increased, net assets reached ¥286.0 billion with an equity ratio of 60.1%, and the annual dividend was raised to ¥131 per share, while guidance for FY2027 projects continued but moderate growth in sales, earnings and dividends, underscoring a stable shareholder-return policy and steady operational trajectory.
The most recent analyst rating on (JP:9989) stock is a Hold with a Yen4400.00 price target. To see the full list of analyst forecasts on Sundrug Co stock, see the JP:9989 Stock Forecast page.
More about Sundrug Co
Sundrug Co., Ltd. is a Japan-based drugstore and pharmacy chain listed on the Tokyo Stock Exchange, operating in the retail healthcare and daily necessities sector. The company focuses on over-the-counter medicines, prescription drugs, cosmetics, and daily goods, targeting consumers seeking convenient, value-oriented health and lifestyle products across its nationwide store network.
Average Trading Volume: 433,498
Technical Sentiment Signal: Hold
Current Market Cap: Yen435.8B
Find detailed analytics on 9989 stock on TipRanks’ Stock Analysis page.